Delgocitinib

Delgocitinib is a Janus kinase (JAK) inhibitor primarily used for its immunomodulatory effects, particularly in treating inflammatory skin conditions like atopic dermatitis. By inhibiting JAK pathways, it reduces inflammation and immune response, which is crucial for managing chronic inflammatory conditions that can impact longevity and overall health.